27252817|t|An Accessible and Pragmatic Experimental Model of Nonalcoholic Fatty Liver Disease
27252817|a|BACKGROUND There is no convenient cheap pragmatic experimental model for Nonalcoholic Fatty Liver Disease (NAFLD)/ Nonalcoholic Steatohepatitis (NASH). Our objective was to create a pragmatic model of NAFLD / NASH. METHODS Sprague-Dawley rats were fed a high-fat, high sugar homemade diet ad libitum for seven weeks. The high-fat, high sugar diet included 59% of energy derived from fat, 30% from carbohydrates, and 11% from protein. Serum levels of fasting glucose, triglyceride, cholesterol, liver enzymes, insulin, and hepatic tumor necrosis factor-alpha (TNF-α) gene expression were determined. Hepatic histology was examined by H&E stain. RESULTS Rats fed the high-fat, high sugar diet developed hepatic steatosis, and a moderate inflammation, which was associated with increased serum levels of liver enzymes, glucose, insulin, triglyceride, cholesterol, and hepatic TNF-α gene expression. CONCLUSION This rat model resembles the key features of human NAFLD / NASH and provides a simple pragmatic experimental model for elucidating the disease prevention and treatment.
27252817	18	46	Pragmatic Experimental Model	T008	C0887965
27252817	50	82	Nonalcoholic Fatty Liver Disease	T047	C0400966
27252817	123	151	pragmatic experimental model	T008	C0887965
27252817	156	188	Nonalcoholic Fatty Liver Disease	T047	C0400966
27252817	190	195	NAFLD	T047	C0400966
27252817	198	226	Nonalcoholic Steatohepatitis	T047	C3241937
27252817	228	232	NASH	T047	C3241937
27252817	265	280	pragmatic model	T008	C0887965
27252817	284	289	NAFLD	T047	C0400966
27252817	292	296	NASH	T047	C3241937
27252817	306	325	Sprague-Dawley rats	T015	C0034715
27252817	337	345	high-fat	T061	C0521974
27252817	347	371	high sugar homemade diet	T061	C1445913
27252817	393	398	weeks	T079	C0439230
27252817	404	412	high-fat	T061	C0521974
27252817	414	429	high sugar diet	T061	C1445913
27252817	446	452	energy	T081	C1442080
27252817	466	469	fat	T109,T168	C0012171
27252817	480	493	carbohydrates	T168	C0453802
27252817	508	515	protein	T168	C0453858
27252817	517	548	Serum levels of fasting glucose	T059	C0583334
27252817	550	562	triglyceride	T059	C0542495
27252817	564	575	cholesterol	T059	C1445957
27252817	577	590	liver enzymes	T059	C0428321
27252817	592	599	insulin	T059	C0428357
27252817	605	612	hepatic	T029	C0205054
27252817	613	640	tumor necrosis factor-alpha	T116,T129	C1456820
27252817	642	647	TNF-α	T116,T129	C1456820
27252817	649	664	gene expression	T045	C0017262
27252817	682	689	Hepatic	T029	C0205054
27252817	690	699	histology	T059	C0344441
27252817	716	725	H&E stain	T059	C0523207
27252817	735	739	Rats	T015	C0034721
27252817	748	756	high-fat	T061	C0521974
27252817	758	773	high sugar diet	T061	C1445913
27252817	784	801	hepatic steatosis	T047	C0015695
27252817	809	830	moderate inflammation	T033	C0522568
27252817	858	897	increased serum levels of liver enzymes	T033	C0857093
27252817	899	906	glucose	T034	C0583332
27252817	908	915	insulin	T034	C1261415
27252817	917	929	triglyceride	T034	C1287372
27252817	931	942	cholesterol	T034	C1287371
27252817	948	955	hepatic	T029	C0205054
27252817	956	961	TNF-α	T116,T129	C1456820
27252817	962	977	gene expression	T045	C0017262
27252817	995	998	rat	T015	C0034721
27252817	999	1004	model	T008	C0887965
27252817	1035	1040	human	T016	C0086418
27252817	1041	1046	NAFLD	T047	C0400966
27252817	1049	1053	NASH	T047	C3241937
27252817	1076	1104	pragmatic experimental model	T008	C0887965
27252817	1125	1143	disease prevention	T061	C0679698
27252817	1148	1157	treatment	T061	C0087111